FALOPPI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.992
EU - Europa 1.333
AS - Asia 1.188
SA - Sud America 375
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.990
Nazione #
US - Stati Uniti d'America 2.942
SG - Singapore 411
BR - Brasile 303
VN - Vietnam 229
IT - Italia 216
RU - Federazione Russa 211
CN - Cina 201
UA - Ucraina 198
SE - Svezia 130
DE - Germania 125
TR - Turchia 113
IE - Irlanda 111
FI - Finlandia 80
DK - Danimarca 76
FR - Francia 68
GB - Regno Unito 65
HK - Hong Kong 61
KR - Corea 43
IN - India 37
CI - Costa d'Avorio 34
MA - Marocco 24
MX - Messico 23
BD - Bangladesh 21
AR - Argentina 19
JP - Giappone 19
CA - Canada 18
ZA - Sudafrica 16
EC - Ecuador 15
NL - Olanda 15
ES - Italia 13
ID - Indonesia 11
IQ - Iraq 11
CO - Colombia 10
VE - Venezuela 9
CL - Cile 8
DZ - Algeria 8
MY - Malesia 8
PL - Polonia 6
KE - Kenya 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
AT - Austria 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
TN - Tunisia 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
ET - Etiopia 1
GR - Grecia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.990
Città #
Ashburn 534
Singapore 267
Chandler 253
Fairfield 219
Jacksonville 210
Dallas 125
Wilmington 125
San Jose 123
Dublin 110
Boardman 100
Seattle 92
New York 91
Woodbridge 89
Ho Chi Minh City 75
Centro 73
Houston 72
Cambridge 66
Ann Arbor 61
Hong Kong 57
Hanoi 55
Beijing 53
Des Moines 53
Los Angeles 52
The Dalles 48
Lawrence 44
Moscow 44
Princeton 44
San Mateo 44
Lauterbourg 38
Turin 35
Abidjan 33
Munich 24
Helsinki 23
São Paulo 22
Orem 20
Tokyo 19
London 18
Turku 18
Hefei 17
San Diego 16
Chennai 15
Atlanta 12
Chicago 11
Johannesburg 11
Rio de Janeiro 11
Buffalo 10
Santa Clara 10
Frankfurt am Main 9
Guayaquil 9
Manchester 9
Montreal 9
Pune 9
Amsterdam 8
Denver 8
Izmir 8
Paris 8
Stockholm 8
Wuxi 8
Brasília 7
Columbus 7
Fortaleza 7
Porto Alegre 7
San Francisco 7
Belo Horizonte 6
Brooklyn 6
Da Nang 6
Mexico City 6
Santiago 6
Washington 6
Bến Tre 5
Curitiba 5
Montevideo 5
Norwalk 5
Poplar 5
Shanghai 5
St Petersburg 5
Warsaw 5
Bogotá 4
Cagliari 4
Campinas 4
Dhaka 4
Fayetteville 4
Haiphong 4
Kilburn 4
Milan 4
Mumbai 4
Nairobi 4
New Delhi 4
Portland 4
Thái Nguyên 4
Wuhan 4
Ancona 3
Ankara 3
Biên Hòa 3
Bắc Giang 3
Cairo 3
Caracas 3
Caxias do Sul 3
City of London 3
Council Bluffs 3
Totale 3.829
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 210
Immunotherapy in genitourinary cancers: Where are we going? 205
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 194
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 193
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 190
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 174
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 170
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 164
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 160
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 157
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 152
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 152
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 149
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 149
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 147
Panitumumab for the treatment of metastatic colorectal cancer: A review 144
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 143
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 141
Trattamento del carcinoma del pancreas. Attualità e prospettive 139
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 134
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 134
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 134
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 134
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 132
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 130
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 128
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 128
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 127
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 124
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 123
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 123
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 122
Palliative treatment 118
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 116
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 112
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 106
Gastric cancer: Therapeutic choices in advanced disease 105
Tracking the 2015 gastrointestinal cancers symposium: Bridging cancer biology to clinical gastrointestinal oncology 105
Selecting the best treatment for an individual patient. 104
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 103
Cetuximab: still an option in the treatment of pancreatic cancer? Expert Opin Biol Ther. 2013 May;13(5):791-801 93
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 88
Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice 85
Totale 6.079
Categoria #
all - tutte 25.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 92 67 33
2021/2022357 28 82 7 6 2 23 15 24 20 54 26 70
2022/2023745 51 105 58 55 47 119 1 44 168 3 78 16
2023/2024388 59 4 39 50 60 104 6 4 1 6 7 48
2024/2025801 112 71 12 11 49 29 102 31 141 58 100 85
2025/20262.220 151 223 134 265 313 164 381 219 168 202 0 0
Totale 6.079